BCL2A1 Rabbit Polyclonal Antibody
CNY 5,808.00
Cited in 1 publication. |
CNY 300.00
CNY 1,430.00
CNY 3,080.00
Specifications
Product Data | |
Applications | IF, IHC, WB |
Recommend Dilution | WB: 0.5 - 2 ug/mL, ICC: 10 ug/mL, IF: 20 ug/mL |
Reactivity | Human, Mouse |
Host | Rabbit |
Clonality | Polyclonal |
Immunogen | Bfl-1 antibody was raised against a 14 amino acid peptide from near the carboxy terminus of human Bfl-1. |
Formulation | PBS containing 0.02% sodium azide. |
Concentration | 1ug/ul |
Purification | Affinity chromatography purified via peptide column |
Conjugation | Unconjugated |
Storage Condition | Store at -20°C as received. |
Gene Name | BCL2 related protein A1 |
Database Link | |
Background | Apoptosis plays a major role in normal organism development, tissue homeostasis, and removal of damaged cells and is caused by caspase activation. Proteins that comprise the Bcl-2 family appear to control the activation of these enzymes. One such member is multi-domain antiapoptotic protein Bfl-1, which is overexpressed in stomach and other cancers. Bfl-1 can interact with Bax and suppress apoptosis by inhibiting the release of cytochrome c and caspase-3 activation. It is upregulated in cisplatin-resistant human bladder tumor, suggesting that its expression may be important for cisplatin resistance and inhibition of apoptosis in cancer cells. At least two isoforms of Bfl-1 are known to exist. Presumably due to post-translational modifications, Bfl-1 is often observed at higher molecular weight in SDS-PAGE than its predicted molecular weight would suggest. |
Synonyms | ACC-1; ACC-2; ACC1; ACC2; BCL2L5; BFL1; GRS; HBPA1 |
Reference Data |
Citations (1)
The use of this Antibodies has been cited in the following citations: |
---|
Differentiation of acute myeloid leukemia (AML) cells with ATRA reduces 18 F-FDG uptake and increases sensitivity towards ABT-737-induced apoptosis.
,null,
Leukemia & lymphoma
,PubMed ID 33140666
[BCL2A1]
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |